Abstract
This article discusses the common and uncommon side effects of heparin and heparin-like therapy. Most attention is devoted to heparin-induced thrombocytopenia, as it is the most clinically aggressive adverse reaction. Additionally, less common and several newly reported side effects are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 259-282 |
Number of pages | 24 |
Journal | Hematology/Oncology Clinics of North America |
Volume | 17 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2003 |
ASJC Scopus subject areas
- Hematology
- Oncology